# Treatment Outcome Between Mycobacterium Abscessus Infection in Chronic Lung Disease and Acquired Interferon-gamma Autoantibody Syndrome

> **NCT05354583** · — · COMPLETED · sponsor: **King Chulalongkorn Memorial Hospital** · enrollment: 36 (actual)

## Conditions studied

- Mycobacterium Abscessus Infection
- Adult-Onset Immunodeficiency With Acquired Anti-Interferon-Gamma Autoantibodies
- Nontuberculous Mycobacterial Pulmonary Infection

## Interventions

- **DRUG:** Appropriate treatment

## Key facts

- **NCT ID:** NCT05354583
- **Lead sponsor:** King Chulalongkorn Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-15
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05354583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05354583, "Treatment Outcome Between Mycobacterium Abscessus Infection in Chronic Lung Disease and Acquired Interferon-gamma Autoantibody Syndrome". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05354583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*